Skip to main content
. 2022 Nov 7;13:882803. doi: 10.3389/fphar.2022.882803

TABLE 4.

League table of results for BUT score change from baseline and TEAEs.

BUT change from baseline
Treatment-emergent AEs Placebo −0.02 (−1.04, 1.01) −0.13 (−0.78, 0.52) −0.35 (−1.34, 0.64) −0.44 (−0.92, 0.05) −0.62 (−1.10,−0.14) −0.74 (−1.84, 0.36) −0.99 (−1.52,−0.46)
2.41 (−3.78, 8.60) Clacier® −0.12 (−1.33, 1.10) −0.33 (−1.76, 1.09) −0.42 (−1.55, 0.71) −0.60 (−1.74, 0.53) −0.72 (−2.22, 0.78) −0.98 (−2.13, 0.18)
N/A N/A CyclASol® −0.22 (−1.40, 0.97) −0.30 (−1.12, 0.51) −0.49 (−1.22, 0.25) −0.60 (−1.84, 0.63) −0.86 (−1.70, −0.02)
2.55 (−4.02, 9.12) 0.14 (−8.89, 9.16) N/A Zirun® −0.09 (−1.19, 1.01) −0.27 (−1.37, 0.83) −0.39 (−1.87, 1.09) −0.64 (−1.77, 0.48)
N/A N/A N/A N/A Cequa® −0.18 (−0.88, 0.52) −0.30 (−1.51, 0.92) −0.55 (−1.27, 0.16)
1.90 (−0.26, 4.06) 0.51 (−6.04, 7.07) N/A 0.65 (−5.55, 6.85) N/A Restasis® −0.12 (−1.10, 0.86) −0.37 (−1.10, 0.35)
2.62 (−2.33, 7.57) 0.21 (−7.71, 8.13) N/A 0.07 (−7.56, 7.71) N/A 0.72 (−3.73, 5.17) TJ Cyporin® −0.26 (−1.48, 0.97)
0.27 (−4.10, 4.63) 2.14 (−5.43, 9.71) N/A 2.28 (−5.61, 10.16) N/A 1.63 (−3.24, 6.50) 2.35 (−4.25, 8.95) Ikervis®

Each cell contains the odds ratio (OR) and 95% confidence interval for BUT changes and TEAEs; the comparison should be read from left to right. Bold numbers indicate statistically significant differences. Inline graphicBUT score change from baseline, Inline graphicST score change from baseline; N/A, data not available.